BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 231 filers reported holding BALCHEM CORP in Q2 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $16,716,000 | -0.4% | 204,473 | -1.8% | 0.37% | +6.3% |
Q4 2017 | $16,785,000 | +9.4% | 208,253 | +10.3% | 0.35% | +5.4% |
Q3 2017 | $15,341,000 | +14.2% | 188,723 | +9.2% | 0.33% | +16.5% |
Q2 2017 | $13,432,000 | +3.8% | 172,843 | +10.1% | 0.28% | +2.2% |
Q1 2017 | $12,940,000 | -1.7% | 157,000 | +0.1% | 0.28% | -6.1% |
Q4 2016 | $13,167,000 | +32.6% | 156,900 | +22.5% | 0.30% | +57.1% |
Q3 2016 | $9,932,000 | -15.6% | 128,100 | -35.1% | 0.19% | -19.2% |
Q2 2016 | $11,774,000 | +1.7% | 197,380 | +5.7% | 0.23% | +2.2% |
Q1 2016 | $11,580,000 | +1.7% | 186,710 | -0.3% | 0.23% | +5.0% |
Q4 2015 | $11,390,000 | +3.9% | 187,330 | +3.8% | 0.22% | -2.7% |
Q3 2015 | $10,964,000 | +21.5% | 180,420 | +11.4% | 0.22% | +39.1% |
Q2 2015 | $9,026,000 | +46.1% | 161,980 | +45.2% | 0.16% | +49.1% |
Q1 2015 | $6,179,000 | -16.8% | 111,580 | +0.1% | 0.11% | -16.3% |
Q4 2014 | $7,429,000 | – | 111,480 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SANTA MONICA PARTNERS LP | 425,686 | $49,048,000 | 36.25% |
Conestoga Capital Advisors, LLC | 939,134 | $108,207,000 | 1.72% |
Tributary Capital Management, LLC | 197,207 | $22,722,000 | 1.63% |
Ellsworth Advisors, LLC | 16,335 | $1,882,000 | 1.36% |
GENEVA CAPITAL MANAGEMENT LLC | 693,677 | $79,926,000 | 1.35% |
Brown Capital Management | 1,391,418 | $160,319,000 | 1.11% |
BARD ASSOCIATES INC | 107,550 | $12,390,000 | 0.98% |
Advantage Alpha Capital Partners LP | 38,370 | $4,421,000 | 0.97% |
MOODY ALDRICH PARTNERS LLC | 50,270 | $5,792,000 | 0.94% |
Cutter & CO Brokerage, Inc. | 29,369 | $3,384,000 | 0.89% |